Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lupus nephritis

J C Davis1, I O Tassiulas, D T Boumpas

  • 1National Institutes of Health, Arthritis and Rheumatism Branch, Bethesda, MD 20892-1828, USA.

Current Opinion in Rheumatology
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Cadaveric Study on the Variations in the Infraclavicular Part of Brachial Plexus in Axillary Region and Upper Arm.

BioMed research international·2025
Same author

Delayed hypertensive crisis after intracavernosal phenylephrine for penile plication.

Anaesthesia reports·2025
Same author

Atmospheric Pressure Plasma Functionalization of Sealed PDMS Microfluidics: Application to Capillary Pumping and Enhanced Cell Growth.

ChemPlusChem·2024
Same author

Regional European genetic ancestry predicts type I interferon level and risk of severe viral infection.

QJM : monthly journal of the Association of Physicians·2024
Same author

Double Vagina.

The Chicago medical journal·2023
Same author

Risk factors for recurrent falls in older adults: A systematic review with meta-analysis.

Maturitas·2020
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Lupus nephritis involves immune and nonimmune factors, with genetics influencing disease risk and outcomes. New therapies are needed due to current treatment limitations and drug toxicity.

Area of Science:

  • Nephrology
  • Immunology
  • Genetics

Background:

  • Lupus nephritis pathogenesis involves complex immune and nonimmune mechanisms.
  • Genetic factors, such as Fc gamma RIIa gene polymorphisms, are linked to nephritis development and outcomes in lupus patients.
  • Current treatments, including immunosuppressants, hypertension, and hyperlipidemia management, are essential but have limitations.

Purpose of the Study:

  • To elucidate fundamental questions in lupus nephritis pathogenesis.
  • To highlight the role of genetic factors in disease predisposition and outcomes.
  • To discuss the need for alternative therapeutic strategies beyond current immunosuppressive regimens.

Main Methods:

  • Review of recent findings on lupus nephritis pathogenesis.

Related Experiment Videos

  • Analysis of genetic linkage studies in lupus-prone mice.
  • Examination of Fc gamma RIIa gene polymorphisms in human populations.

    • Main Results:

    • Genetic factors significantly contribute to nephritis susceptibility and outcomes in lupus.
    • Fc gamma RIIa gene polymorphisms correlate with renal disease in diverse ethnic groups.
    • Despite effective immunosuppressive therapy, many patients experience incomplete response or relapse, and drug toxicity is a concern.

    Conclusions:

    • Genetic predisposition and outcome are influenced by genetic factors in lupus nephritis.
    • Effective management requires immunosuppression, hypertension, and hyperlipidemia control.
    • Development of novel therapeutic regimens targeting inflammatory and other mediators is crucial for improved lupus nephritis management.